BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
BioMarin (NASDAQ: BMRN) announced that Alexander Hardy, President and CEO, will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BioMarin (NASDAQ: BMRN) announced that Alexander Hardy, President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 11:15 am PT / 2:15 pm ET in San Francisco.
The company plans to announce certain preliminary financial results for the year ended December 31, 2025 during the presentation. An audio webcast will be available live and an archived version will be posted on the company's investor website for a limited time.
Details
News Market Reaction – BMRN
On Jan 9, the first trading day after this news, BMRN closed 2.32% below the previous close.
Data tracked by StockTitan Argus for the Jan 9 session.
Key Figures
- Conference edition
- 44th Annual
- J.P. Morgan Healthcare Conference
- Presentation date
- January 12, 2026
- Scheduled JPM conference presentation
- Presentation time PT
- 11:15 am PT
- JPM conference slot
- Fiscal year-end
- December 31, 2025
- Preliminary results to be discussed
Historical Context
-
All-cash Amicus acquisition to expand rare disease portfolio and revenues.
-
Investor presentation at Jefferies healthcare conference with webcast access.
-
FDA Priority Review acceptance for PALYNZIQ sBLA in adolescents with PKU.
-
Q3 2025 revenue growth but GAAP loss and lower Non-GAAP EPS guidance.
-
Announcement of Q3 2025 results call and webcast scheduling details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael,
Contacts: | |
Investors | Media |
Traci McCarty | Marni Kottle |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (650) 374-2803 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt--215-pm-et-in-san-francisco-ca-302656804.html
SOURCE BioMarin Pharmaceutical Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.